Iterum Therapeutics PLC expected to post a loss of $1.05 a share - Earnings Preview
* Iterum Therapeutics PLC ITRM.OQ ITRM.O is expected
to report results on November 10.
*
* Refinitiv's mean analyst estimate for Iterum Therapeutics
PLC
is for a loss of $1.05 per share.
* The one available analyst rating on the shares is
"hold".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
This summary was machine generated November 8 at 19:33 GMT. All
figures in US dollars unless otherwise stated
Recent news on Iterum Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Entergy, US natgas stocks, Brown-Forman, Datacentrex
U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services
Iterum Therapeutics plummets after filing wind up petition
Iterum seeks court-led dissolution amid cash crisis, inability to raise funds (updated)
Iterum files wind-up petition due to limited cash, inability to raise equity